This review synthesizes current evidence establishing the IGF family—including ligands, receptors, binding proteins (IGFBPs), and related proteins (IGFBPLs)—as a central regulatory hub in PAH pathogenesis. This evidence concerns the gene IGF1 and pulmonary arterial hypertension.